Amarantus BioSciences, Inc. Provides Update on #C4CT Concussion Awareness Summit on June 21 in Minneapolis

Published: May 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, provided an update on the Coalition for Concussion Treatment (#C4CT) Concussion Awareness Summit (#C4CT Summit) being held at the Minneapolis Club in Minnesota on June 21, 2013. (Please note change from previous date of June 19.)

Help employers find you! Check out all the jobs and post your resume.

Back to news